Discover
ARMP
Armata Pharmaceuticals, Inc.
5.88
100 x undefined
100 x undefined
bid
ask
-
0.60
9.26%
100 @ 04:17 AM
6.34 +0.46 (7.82%)
| Ytd | -6.37% | |
| 1y | 211.11% |
5.87
day range
6.53
1.93
52 week range
16.34
| Open | 6.53 | Prev Close | 6.48 | Low | 5.87 | High | 6.53 | Mkt Cap | 215.86M |
| Vol | 62.29K | Avg Vol | 109.28K | EPS | -7.78 | P/E | N/A | Forward P/E | -1.30 |
| Beta | 0.81 | Short Ratio | 0.86 | Inst. Own | 3.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 8.49 | 200-d Avg | 7.37 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 9.57M | ||
| Research and Development Expense | 6.11M | ||
| Selling, General and Administrative Expense | 3.46M | ||
| Operating Income | -9.57M | ||
| Interest Expense | 5.56M | ||
| Net Income | -115.35M | ||
| Net Income Common Stock | -115.35M | ||
| Net Income Common Stock (USD) | -115.35M | ||
| Consolidated Income | -115.35M | ||
| Earnings per Basic Share | -3.16 | ||
| Earnings per Basic Share (USD) | -3.16 | ||
| Earnings per Diluted Share | -3.16 | ||
| Earning Before Interest & Taxes (EBIT) | -109.79M | ||
| Earning Before Interest & Taxes (USD) | -109.79M | ||
| Weighted Average Shares | 36.53M | ||
| Weighted Average Shares Diluted | 36.53M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.87M | ||
| Cash and Equivalents (USD) | 8.87M | ||
| Trade and Non-Trade Receivables | 47.00K | ||
| Current Assets | 5.95M | ||
| Property, Plant & Equipment Net | 45.18M | ||
| Total Assets | 69.80M | ||
| Debt Current | 4.59M | ||
| Total Debt | 373.67M | ||
| Current Liabilities | 9.23M | ||
| Debt Non-Current | 369.08M | ||
| Total Liabilities | 381.39M | ||
| Accumulated Retained Earnings (Deficit) | -616.88M | ||
| Shareholders Equity | -311.59M | ||
| Shareholders Equity (USD) | -311.59M | ||
| Assets Non-Current | 63.85M | ||
| Total Debt (USD) | 373.67M | ||
| Goodwill and Intangible Assets | 3.49M | ||
| Liabilities Non-Current | 372.16M | ||
| Trade and Non-Trade Payables | 1.45M | ||
| Tax Liabilities | 3.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 457.00K | ||
| Net Cash Flow from Financing | 641.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.20M | ||
| Capital Expenditure | -63.00K | ||
| Issuance (Purchase) of Equity Shares | 704.00K | ||
| Net Cash Flow from Investing | -63.00K | ||
| Net Cash Flow from Operations | -5.78M | ||
| Share Based Compensation | 1.08M | ||